Related Experiment Video

Updated: Oct 13, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Pharmacokinetics of m-nifedipine in rabbits after intravenous injection

J Ma1, J W Xie, Z P Jia

  • 1Department of Pharmacy, General Hospital of Lanzhou Command of PLA, China.

Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|March 1, 1996
PubMed
Abstract

Insights

This study found that m-Nifedipine (m-Nif) exhibits dose-independent pharmacokinetics in rabbits within the tested intravenous dosage range. The drug is widely distributed and rapidly eliminated, suggesting consistent absorption and metabolism across different doses.

Area of Science:

  • Pharmacology
  • Drug Metabolism and Pharmacokinetics

Background:

  • m-Nifedipine (m-Nif) is a novel, photostable dihydropyridine calcium channel blocker.
  • Dihydropyridine calcium channel antagonists are crucial for managing hypertension and angina.
  • Unlike nifedipine, m-Nif offers enhanced stability when exposed to light while maintaining similar antihypertensive efficacy.

Purpose of the Study:

  • To investigate the dose-dependent pharmacokinetic profile of m-Nifedipine (m-Nif) following intravenous administration in rabbits.
  • To establish baseline pharmacokinetic parameters for m-Nif in an animal model.

Main Methods:

  • Conscious rabbits (n=15) were administered intravenous m-Nif at doses of 0.5, 1, and 2 mg/kg.
  • Plasma concentrations of m-Nif were quantified using a validated High-Performance Liquid Chromatography (HPLC) method.
  • Pharmacokinetic parameters were determined by fitting concentration-time data to a two-compartment model.

Main Results:

  • The pharmacokinetic analysis revealed wide distribution and relatively rapid elimination of m-Nif in rabbits.
  • Key parameters at 1 mg/kg i.v. included Vd (0.37 L/kg), T1/2 alpha (6.4 min), T1/2 beta (84 min), AUC (94 mg·min/L), and Cl (0.65 L/kg/h).
  • No statistically significant differences in clearance (Cl) or terminal half-life (T1/2 beta) were observed across the tested dose groups, although AUC (normalized for body weight) showed a correlation with dose.

Conclusions:

  • Intravenous administration of m-Nif (0.5-2 mg/kg) in rabbits does not result in dose-dependent pharmacokinetics.
  • m-Nif is characterized by broad distribution and rapid elimination in this animal model.
  • These findings provide essential pharmacokinetic data for m-Nif, a promising alternative to existing calcium channel blockers.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection00:59

Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...